Zum Seiteninhalt springen

Cardiovascular diseases are the main cause of death worldwide. Heart failure is a global pandemic and is increasing in prevalence, indicating the need for better treatment options. The research field focuses at finding patient-specific therapy concepts for the treatment of heart failure. With inflammation being an important predictor for a worse outcome in heart failure, we search for novel or repurposed anti-inflammatory and immunomodulatory therapies, including the evaluation of cell-based therapies. Our research is further directed at finding strategies which lead to cardiomyocyte regeneration.With valve disease being one of the causes of heart failure and the degeneration of existing heart valves protheses requiring multiple re-interventions, one arm of our research is focused at developing regenerative heart valves.

  • Univ.-Prof. Dr. med. Carsten Tschöpe (FHFA)

    BIH Center für Regenerative Therapien

    Kontaktinformationen
    Anschrift:Augustenburgerplatz 1
    13353 Berlin, Germany

    E-Mail:Carsten.tschoepe[at]charite.de
  • Sophie van Linthout

Aims

  • Stratification of heart failure patients based on phenomapping
  • Identification of patient-specific therapy options (precision medicine)
  • Immunocardiology
  • Development of novel (cell-based) therapies for the treatment of heart failure
  • Development of cardiomyocyte regeneration strategies
  • Development of regenerative heart valves

Arbeitsgruppen

  • Arbeitsgruppe

    Extracellular Vesicles as a Next Generation Cardioprotective Agent

    Timo Z. Nazari-Shafti

    Our junior group is part of the Translational Cardiovascular Regenerative Technologies research group (Emmert Lab) and aims to establish an interdisciplinary platform for extracellular vesicle based next generation advanced therapies for cardioprotection and myocardial regeneration. Extracellular…

    Mehr erfahren
  • Arbeitsgruppe

    Immunokardiologie

    Carsten Tschöpe

    Mehr erfahren
  • Arbeitsgruppe

    In situ Tissue Engineering

    Michael Sittinger

    Michael Sittinger ist ein Pionier der Tissue Engineering Forschung und hat mit seinem Team fast 30 Jahre Erfahrung auf diesem Fachgebiet und eigene Entwicklungen zur Marktreife geführt. Die aktuelle Arbeit des Forschungsbereichs befasst sich insbesondere mit den individuellen Herausforderungen der…

    Mehr erfahren
  • Arbeitsgruppe

    Translational Cardiovascular Regenerative Technologies

    Maximilian Emmert

    The concept of regenerative approaches comprising of cell-based therapies and cardiovascular tissue engineering technologies and hybrid solutions represents a promising, next generation approach to treat cardiovascular diseases. In our interdisciplinary group we particularly aim on the clinical…

    Mehr erfahren

BIH Center for Regenerative Therapies (BCRT)

Kontaktinformationen
Anschrift:Charité - Universitätsmedizin Berlin
Campus Virchow-Klinikum
Augustenburger Platz 1
(Besucher: Föhrer Str. 15)

13353 Berlin
Telefon:+49 (0)30 450 539 500
E-Mail:contact[at]b-crt.de